F Dx Advisors, Inc. Seres Therapeutics, Inc. Transaction History

F Dx Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 08, 2021	SELL	$5.46 - $22.6 $53,660 - $222,112	-9,828 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$18.46 - $24.36 $68,283 - $90,107	-3,699 Reduced 27.35%	9,828 $234,000
Q1 2021 Apr 14, 2021	BUY	$17.66 - $28.92 $233,959 - $383,132	13,248 Added 4748.39%	13,527 $279,000
Q1 2021 Apr 13, 2021	SELL	$17.66 - $28.92 $248,140 - $406,354	-14,051 Reduced 98.05%	279 $5,000
Q4 2020 Feb 08, 2021	SELL	$23.25 - $37.73 $13,066 - $21,204	-562 Reduced 3.77%	14,330 $351,000
Q3 2020 Nov 12, 2020	BUY	$3.74 - $28.74 $16,949 - $130,249	4,532 Added 43.75%	14,892 $422,000
Q2 2020 Jul 22, 2020	BUY	$3.04 - $6.2 $31,494 - $64,232	10,360 New	10,360 $49,000

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $103M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.